Enhance your practice with CME and tools that focus on the management of neurological conditions.
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Exploring Genetic Links Between EBV Clearance and MS Risk
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD
David Weisman, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Navigating Emerging Biomarkers in MS Care
Discharge Planning After Myasthenic Crisis
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Precision Medicine for Myasthenia Gravis
Outcome Measures Capture Progression in Late-Onset TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.